Page last updated: 2024-08-24

topotecan and Diffuse Mixed Small and Large Cell Lymphoma

topotecan has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (20.00)	18.2507
2000's	12 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Couban, S; Crump, M; Eisenhauer, E; Gluck, S; Hoskins, P; Maksymiuk, A; Matthews, S; Meyer, R; Rudinskas, L; Zanke, B	1
Fu, ZZ; Ma, R; Qiu, HY; Ruan, CG; Sun, AN; Tang, XW; Wu, DP	1
Fischer, L; Jahnke, K; Kirchen, H; Klasen, HA; Korfel, A; Thiel, E	1
Coutinho, F; Del Giglio, A; Manhani, AR; Velasquez, WS	1
Fayad, L; Goy, A; Hagemeister, FB; Loyer, E; McLaughlin, P; Pro, B; Rodriguez, MA; Romaguera, J; Younes, A	1
Bartlett, NL; Canellos, G; Cheson, BD; Eder, JP; Johnson, JL; Niedzwiecki, D; Smith, SM	1
Coutinho, F; Dantas, AA; Del Giglio, A; Manhani, AR	1
Batchelor, T; Betensky, R; Hochberg, F; Voloschin, AD; Wen, PY	1
Kraut, E; Muller, MT; Staubus, A; Subramanian, D; Young, DC	1
Cabanillas, F	1
Ahmed, T; Durrani, H; Kancherla, RR; Mannancheril, A; Nair, JS; Seiter, K; Tse-Dinh, YC	1
Kancherla, R; Nair, JS; Seiter, K; Traganos, F; Tse-Dinh, YC	1
Cabanillas, F; Hagemeister, FB; McLaughlin, P; Palmer, JL; Preti, HA; Rodriguez, MA; Romaguera, JE; Samuels, BI; Younes, A	1
Balcerzak, SP; Davis, MP; Jacobs, SA; Kraut, EH; Young, D	1

Reviews

1 review(s) available for topotecan and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
The role of topoisomerase-I inhibitors in the treatment of non-Hodgkin's lymphoma. Seminars in hematology, 1999, Volume: 36, Issue:4 Suppl 8 Topics: Antineoplastic Combined Chemotherapy Protocols; Enzyme Inhibitors; Humans; Lymphoma, Non-Hodgkin; Paclitaxel; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan	1999

Trials

11 trial(s) available for topotecan and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study. Leukemia & lymphoma, 2002, Volume: 43, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Topotecan	2002
Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan. Neurology, 2004, May-25, Volume: 62, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prospective Studies; Remission Induction; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome	2004
Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial. Acta haematologica, 2004, Volume: 112, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Glucocorticoids; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Topotecan; Treatment Outcome	2004
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma. Leukemia & lymphoma, 2006, Volume: 47, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Injections, Intravenous; Injections, Subcutaneous; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutrophils; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Recurrence; Topotecan; Treatment Outcome	2006
Sequential doxorubicin and topotecan in relapsed/refractory aggressive non-Hodgkin's lymphoma: results of CALGB 59906. Leukemia & lymphoma, 2006, Volume: 47, Issue:8 Topics: Adult; Aged; Burkitt Lymphoma; Disease-Free Survival; Doxorubicin; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Remission Induction; Salvage Therapy; Topoisomerase I Inhibitors; Topotecan	2006
Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial. Acta haematologica, 2006, Volume: 116, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Recurrence; Salvage Therapy; Survival Analysis; Topotecan	2006
Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma. Journal of neuro-oncology, 2008, Volume: 86, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Disease-Free Survival; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Topotecan; Treatment Outcome	2008
Analysis of topoisomerase I/DNA complexes in patients administered topotecan. Cancer research, 1995, May-15, Volume: 55, Issue:10 Topics: Antineoplastic Agents; Camptothecin; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; HeLa Cells; Humans; Lymphoma, Non-Hodgkin; Melanoma; Topotecan	1995
Evaluation of topotecan and etoposide for non-Hodgkin lymphoma: correlation of topoisomerase-DNA complex formation with clinical response. Cancer, 2001, Feb-01, Volume: 91, Issue:3 Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Humans; Isoenzymes; Lymphoma, Non-Hodgkin; Male; Middle Aged; RNA, Messenger; Topotecan; Treatment Outcome	2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:7 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Neutrophils; Paclitaxel; Topotecan; Treatment Outcome	2001
A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study. Cancer investigation, 2002, Volume: 20, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Topoisomerase I Inhibitors; Topotecan	2002

Other Studies

3 other study(ies) available for topotecan and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
[Topotecan-based combined chemotherapy for refractory or relapsed hematologic malignancies]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2003, Volume: 25, Issue:6 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Humans; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Topotecan	2003
Action of topoisomerase targeting drugs on non-Hodgkin's lymphoma and leukemia. Correlation of clinical and cell culture studies. Annals of the New York Academy of Sciences, 2000, Volume: 922 Topics: Acute Disease; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase I as Topic; Cytarabine; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Isoenzymes; Leukemia; Leukocytes; Lymphoma, Non-Hodgkin; Mitoxantrone; Polymerase Chain Reaction; RNA, Messenger; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Topotecan	2000
Lymphoma trials recruiting. AIDS patient care and STDs, 1998, Volume: 12, Issue:4 Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Lymphoma, Non-Hodgkin; Patient Selection; Spermine; Topotecan	1998